North Star Investment Management Corp.
Position in DFTX — Definium Therapeutics, Inc.
CIK 1342857
CHICAGO, IL
Position in DFTX
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$143,091
New position
Shares Held
7,571
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026North Star Investment Management Corp. holds $819,477 across 35 Biotechnology names. DFTX ranks #1 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
This page
|
7,571 | $143,091 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
3,900 | $129,558 | |
| 3 | ATAI |
AtaiBeckley Inc.
|
28,275 | $100,093 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
3,058 | $99,507 | |
| 5 | CMPX |
Compass Therapeutics, Inc.
|
12,500 | $66,125 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,260 | $54,041 | |
| 7 | ALT |
Altimmune, Inc.
|
17,000 | $52,360 | |
| 8 | GHRS |
GH Research PLC
|
2,200 | $30,932 |
All Filings in DFTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $143,091 | 7,571 | Shares | Sole | 2026-04-23 | |
| No filing history on record for this holder in this stock. | ||||||